ARCHIVES OF NEUROLOGY, vol.69, no.10, pp.1259-1269, 2012 (SCI-Expanded)
Objective: To assess the impact of fingolimod (FTY720) therapy on magnetic resonance imaging measures of inflammatory activity and tissue damage in patients participating in a 2-year, placebo-controlled, phase 3 study.